CLICHY, France--(BUSINESS WIRE)--CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French ...

First-of-its-kind heart pump implanted in Australia, based on a breakthrough wave membrane technology. Unlike existing devices, CorWave’s technology does not eliminate the effects of the native ...

CorWave Announces the Appointment of Dawn Sadlowski-Buisserez as Vice President of Operations to Support the Ramp-Up of Production CorWave, a French company developing and manufacturing innovative ...

Primary endpoint successfully met, no device-related serious adverse events at 30 days Pulsatility preserved throughout the study with beat-to-beat valve opening Successful transplantation after 84 ...

Corwave SA raised €26 million (US$28 million) in the second close of its series C funding round taking the total amount to €61 million. The funds will go toward the industrial development of the ...

A small French company has some mighty big shoes to fill in the left ventricular assist device (LVAD) market. When Medtronic pulled the plug on its embattled HeartWare ventricular assist device in ...

Blood pump maker CorWave reeled in a €15.5 million ($17.1 million) Series B, which the French company will put toward a first-in-man study of its novel left ventricular assist device technology, which ...

CorWave, a French company developing and manufacturing innovative cardiac assist devices, announces the appointment of Dawn Sadlowski-Buisserez as Vice President of Operations. Dawn ...

CorWave, a clinical-stage medical device company dedicated to the fight against heart failure, today announced the presentation of interim results from its FIH study evaluating its Left Ventricular ...